Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fenugreek glycosides is a botanical extract formulation developed by The More Life Company (formerly Mountain Valley MD) utilizing its proprietary Quicksome™ liposomal delivery technology. Formulated as a sublingual quick-dissolve tablet, the product is designed to optimize the delivery, absorption, and bioavailability of standardized fenugreek glycosides. It is primarily being developed to support healthy testosterone levels in men, with potential benefits for muscle mass, strength, energy, libido, and sperm production. Additionally, the formulation is under development for the relief of hot flashes and night sweat symptoms associated with perimenopause and post-menopause.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fenugreek glycosides.